An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis

J Nutr. 2010 Oct;140(10):1714-21. doi: 10.3945/jn.109.119768. Epub 2010 Aug 19.

Abstract

We have previously shown that α-linolenic acid (ALA), a (n-3) PUFA exerts in vitro antiinflammatory effects in the intestine. In this study, we aimed to evaluate its effect on inflammatory and oxidative stress in a colitis model. Colitis was induced in 2 groups at d 0 by intrarectal injection of 2-4-6-trinitrobenzen sulfonic acid (TNBS), whereas the control group received the vehicle. Rats we fed 450 mg . kg(-1) . d(-1) of ALA (TNBS+ALA) while the other colitic group (TNBS) and the control group were fed an isocaloric corn oil formula for 14 d (from d -7 to d 7). RBC fatty acid composition was assessed. Oxidative stress was studied by measuring urinary 8-isoprostanes (8-IP) and colon glutathione (GSH) concentration and inducible nitric oxide synthase (iNOS) expression. Colitis was assessed histologically, by production of proinflammatory mediators, including cytokines, leukotrienes B(4) (LTB(4)), and cyclooxygenase-2 (COX-2) and by nuclear factor-κB (NF-κB) activation. The ALA-rich diet significantly increased the RBC levels of ALA, eicosapentaenoic acid, and docosapentaenoic acid (n-3) compared with the TNBS group (P < 0.01 for all). The beneficial effect of ALA supplementation on oxidative stress was reflected by lower urinary 8-IP levels (P < 0.05), a normalized colon GSH concentration (P < 0.01), and reduced colon iNOS expression (P < 0.05) compared with the TNBS group. ALA also protected against colon inflammation as assessed by lower tumor necrosis factor-α secretion and mRNA level (P < 0.05), reduced NF-κB activation (P = 0.01), and lower colon lipid mediator concentrations such as LTB(4) and COX-2 (P < 0.05) compared with the TNBS group. These findings show that an ALA-rich formula is beneficial to TNBS-induced colitic rats via inhibition of oxidative and inflammatory stress.

MeSH terms

  • Animals
  • Chymotrypsin / metabolism
  • Colitis / chemically induced
  • Colitis / metabolism*
  • Colitis / prevention & control*
  • Colon / chemistry
  • Colon / metabolism
  • Colon / pathology
  • Cytokines / analysis
  • Diet
  • Dinoprost / analogs & derivatives
  • Dinoprost / urine
  • Eicosanoids / biosynthesis
  • Erythrocytes / chemistry
  • Fatty Acids / blood
  • Glutathione / analysis
  • Interferons / analysis
  • Male
  • NF-kappa B / analysis
  • NF-kappa B / drug effects*
  • NF-kappa B / physiology
  • Nitric Oxide Synthase Type II / analysis
  • Oxidative Stress / drug effects*
  • Rats
  • Rats, Sprague-Dawley
  • Trinitrobenzenesulfonic Acid* / administration & dosage
  • alpha-Linolenic Acid / administration & dosage*

Substances

  • Cytokines
  • Eicosanoids
  • Fatty Acids
  • NF-kappa B
  • alpha-Linolenic Acid
  • 8-epi-prostaglandin F2alpha
  • Trinitrobenzenesulfonic Acid
  • Interferons
  • Dinoprost
  • Nitric Oxide Synthase Type II
  • Chymotrypsin
  • Glutathione